News Overview

Prerna Infrabuild will hold a meeting of the Board of Directors of the Company on 20 April 2022

The Board of Minda Industries has approved the appointment of Satish Borwankar as an Additional Director in the category of Non-Executive Independent Director on Board of the company with effect from 12 April 2022

Technocraft Industries India has incorporated a wholly owned subsidiary named Technocraft Specialty Yarns on 08 April 2022

MCX is planning to collaborate with Chittagong Stock Exchange CSE Bangladesh to provide the consultancy services for the establishment of a Commodity derivatives platform in Bangladesh As part of the agreement MCX will provide consultancy services in areas of regulations products clearing and settlement services trading warehousing etc The agreement to this effect is planned to be signed on 12 April 2022 between MCX and […]

Titagarh Wagons announced that an Extra Ordinary General Meeting EGM of the Company will be held on 10 May 2022

Darshan Orna has revised the meeting of the Board of Directors which was scheduled to be held on 9 April 2022 The meeting will now be held on 14 April 2022

Lasa Supergenerics announced that the Board of Directors of the Company at its meeting held on 11 April 2022 inter alia have recommended the final dividend of Rs 025 per equity Share ie 25Percentage subject to the approval of the shareholders

Nestle India announced that the Board of Directors of the Company at its meeting held on 11 April 2022 has recommended a Interim dividend of Rs25 per share ie250 subject to the approval of the shareholders

Wipro announced that it has acquired Convergence Acceleration Solutions LLC CAS Group a US-based consulting and program management company that specializes in driving large-scale business and technology transformation for Fortune 100 communications service providers CAS Groups deep-rooted client relationships and strong domain expertise combined with Wipros execution capabilities will deliver an end-to-end professional services solution and immediate impact to clients The joint entity will provide […]

Glenmark Pharmaceuticals announced that its subsidiary Glenmark Specialty SA Glenmark received approval from the Indian drug regulator Drug Controller General of India DCGI to conduct a Phase 1 clinical trial of its novel smallmolecule GRC 54276 a hematopoietic progenitor kinase 1 HPK1 inhibitor HPK1 is a key regulator of T cell B cell and dendritic cell-mediated immune responses which improves antitumor immunity by activating and […]